IGF2R polymorphisms and risk of esophageal and gastric adenocarcinomas.
Hoyo C, Schildkraut JM, Murphy SK, Chow WH, Vaughan TL, Risch H, Marks JR, Jirtle RL, Calingaert B, Mayne S, Fraumeni J Jr, Gammon MD.
Hoyo C, et al. Among authors: calingaert b.
Int J Cancer. 2009 Dec 1;125(11):2673-8. doi: 10.1002/ijc.24623.
Int J Cancer. 2009.
PMID: 19626700
Free PMC article.